| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.51B | — | +35.5% |
| Gross Profit | $1.35B | — | +41.4% |
| R&D Expense | $541.2M | — | +12.3% |
| SG&A Expense | $555.1M | — | +20.9% |
| Operating Income | $249.9M | — | +2151.0% |
| Pre-tax Income | $259.2M | — | +1140.3% |
| Income Tax | $31.9M | — | +62.3% |
| Net Income | $227.4M | — | — |
| EPS (Basic) | $0.16 | — | — |
| EPS (Diluted) | $0.15 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.79B | +5.4% | +90.4% |
| Accounts Receivable | $938.0M | +8.4% | +30.8% |
| Inventory | $681.6M | +12.1% | +37.8% |
| Current Assets | $6.60B | +5.9% | +69.4% |
| Total Assets | $8.55B | +4.5% | +46.4% |
| Current Liabilities | $1.81B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $201.3M | — | +356.7% |
| Capital Expenditures | $40.8M | — | -27.7% |
| Investing Cash Flow | -$45.5M | — | +62.7% |
| Financing Cash Flow | $68.6M | — | +303.2% |
| Free Cash Flow | $160.5M | — | +1402.6% |
| -8.7% |
| Long-term Debt | $842.9M | +0.8% | +426.3% |
| Total Liabilities | $3.79B | -0.9% | +62.0% |
| Stockholders' Equity | $4.76B | +9.2% | +36.0% |